Highlights Edwards Lifesciences Corporation Xetra

Equities

EWL

US28176E1082

Market Closed - Xetra Other stock markets 11:35:39 2024-05-31 EDT			5-day change	1st Jan Change
80.11 ^EUR	-1.90%		-1.35%	+15.73%

05-23	Some of the biggest splits in Corporate America	RE
05-22	Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Some of the biggest splits in Corporate America	05-23	RE
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	05-13	MT
Edwards Lifesciences hit with Meril's EU antitrust complaint	05-13	RE
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	05-08	CI
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	04-25	RE
Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set	04-25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q1 EPS $0.66, vs. Street Est of $0.64	04-25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Reports Q1 Revenue $1.6B, vs. Street Est of $1.57B	04-25	MT
Edwards Lifesciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Edwards Lifesciences Corporation Revises Earnings Guidance for the Full Year 2024	04-25	CI
Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024	04-25	CI
Edwards Lifesciences Corporation: The story continues	04-23
Edwards Lifesciences Announces the Release of Data from the Hudle Study	04-07	CI
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	03-21	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	03-21	MT
Edwards Lifesciences Announces Large, Real-World Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	03-11	CI
US FDA staff raises no new concerns about Abbott's heart device	02-09	RE
Fed officials fail to convince investors, who are focused on earnings	02-07
Edwards Lifesciences beats quarterly estimates on strong heart device sales	02-06	RE
Edwards Lifesciences' Q4 Adjusted Earnings Unchanged, Sales Rise; Q1, 2024 Guidance Set	02-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am